KEQU Stock Overview
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Kewaunee Scientific Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$64.70 |
| 52 Week High | US$67.20 |
| 52 Week Low | US$27.00 |
| Beta | 0.71 |
| 1 Month Change | 5.87% |
| 3 Month Change | 71.57% |
| 1 Year Change | 125.39% |
| 3 Year Change | 335.40% |
| 5 Year Change | 429.89% |
| Change since IPO | 324.26% |
Recent News & Updates
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Dec 16The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out
Sep 24Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Sep 17
With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case
Sep 10Recent updates
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Dec 16The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out
Sep 24Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Sep 17With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case
Sep 10Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price
Aug 23Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance
Jul 11Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet
Jun 19Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely
Dec 18Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital
Jul 02Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet
Mar 10Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M
Sep 08Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M
Jun 30Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?
Apr 12Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt
Dec 28
Kewaunee Scientific reports Q2 results
Dec 09Shareholder Returns
| KEQU | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.2% | 1.6% | 0.6% |
| 1Y | 125.4% | 14.0% | 22.4% |
Return vs Industry: KEQU exceeded the US Medical Equipment industry which returned 14% over the past year.
Return vs Market: KEQU exceeded the US Market which returned 22.4% over the past year.
Price Volatility
| KEQU volatility | |
|---|---|
| KEQU Average Weekly Movement | 10.7% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: KEQU has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: KEQU's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 1,006 | Thomas Hull | www.kewaunee.com |
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Kewaunee Scientific Corporation Fundamentals Summary
| KEQU fundamental statistics | |
|---|---|
| Market cap | US$187.59m |
| Earnings (TTM) | US$18.75m |
| Revenue (TTM) | US$199.64m |
9.9x
P/E Ratio0.9x
P/S RatioIs KEQU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KEQU income statement (TTM) | |
|---|---|
| Revenue | US$199.64m |
| Cost of Revenue | US$146.53m |
| Gross Profit | US$53.11m |
| Other Expenses | US$34.36m |
| Earnings | US$18.75m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.53 |
| Gross Margin | 26.60% |
| Net Profit Margin | 9.39% |
| Debt/Equity Ratio | 47.1% |
How did KEQU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 00:57 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kewaunee Scientific Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CG Capital |